Gain insight into research trends and influential papers with Research Intelligence.
doi.org/10.1016/j.rmed.2021.106585

Serum GPL core antibody levels are associated with disease activity and treatment outcomes in Mycobacterium avium complex lung disease following first line antibiotic treatment

..., Hiroshi Kida
59
Respiratory Medicine4.30
Volume: 187, Pages: 106585 - 106585
Published: Oct 1, 2021
Abstract
No objective serum biomarkers of disease course or treatment outcome of Mycobacterium avium complex lung disease (MAC-LD) presently exist. Serum IgA antibody levels against the glycopeptidolipid (GPL) core have good diagnostic accuracy for MAC-LD. However, their usefulness for monitoring and predicting disease course and outcome of MAC-LD following first-line antibiotic treatment remains unclear.We conducted a single-center retrospective cohort...
Paper Fields
Paper Details
Title
Serum GPL core antibody levels are associated with disease activity and treatment outcomes in Mycobacterium avium complex lung disease following first line antibiotic treatment
DOI
doi.org/10.1016/j.rmed.2021.106585
Published Date
Oct 1, 2021
Journal
Respiratory Medicine
Volume
187
Pages
106585 - 106585
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.